Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose SLV320 in congestive heart failure during right heart catheterization
2004-000442-21Phase 2Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of derenofylline in heart failure (HF) (4 arms), sponsored by Solvay Pharmaceuticals. Primary endpoint: Maximum change from baseline in pulmonary capillary wedge pressure over first 12 hours on Day 1. Started Jun 2005; status: completed.
02
Drugs
derenofylline
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2004-000442-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000442-21.